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1  | BACKGROUND
Since 2015, microcephaly has received increased awareness be-
cause of its association with outbreaks of Zika virus throughout 
most of Central and South America.1-4 Microcephaly occurs when 
a child's head is smaller than typical and is usually accompanied by 
impaired brain growth and development.5-7 Canonical definitions of 
microcephaly include a newborn or fetal head circumference below 
the third percentile or, similarly, a head circumference at least two 
standard deviations (SDs) below the mean from a reference popula-
tion, for age and gender.5,8 Both definitions of microcephaly have 
been used by the Centers for Disease Control and Prevention (CDC) 
(although the CDC alludes in some places to the need for additional, 
confirmatory evidence)5 and American Academy of Pediatrics (AAP), 
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Abstract
Background: Several health agencies define microcephaly for surveillance purposes 
using a single criterion, a percentile or Z-score cut-off for newborn head circumfer-
ence. This definition, however, conflicts with the reported prevalence of microceph-
aly even in populations with endemic Zika virus.
Objective: We explored possible reasons for this conflict, hypothesising that the def-
inition of microcephaly used in some studies may be incompletely described, lacking 
the additional clinical criteria that clinicians use to make a formal diagnosis. We also 
explored the potential for misclassification that can result from differences in these 
definitions, especially when applying a percentile cut-off definition in the presence of 
the much lower observed prevalence estimates that we believe to be valid.
Methods: We conducted simulations under a theoretical bimodal distribution of head 
circumference. For different definitions of microcephaly, we calculated the sensitiv-
ity and specificity using varying cut-offs of head circumference. We then calculated 
and plotted the positive predictive value for each of these definitions by prevalence 
of microcephaly.
Results: Simple simulations suggest that if the true prevalence of microcephaly is 
approximately what is reported in peer-reviewed literature, then relying on cut-off-
based definitions may lead to very poor positive predictive value under realistic 
conditions.
Conclusions: While a simple head circumference criterion may be used in practice as 
a screening or surveillance tool, the definition lacks clarification as to what consti-
tutes true pathological microcephaly and may lead to confusion about the true preva-
lence of microcephaly in Zika-endemic areas, as well as bias in aetiologic studies.
K E Y W O R D S
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as well as throughout the peer-reviewed literature.5,8 The Society 
for Maternal-Fetal Medicine (SMFM) has recommended that iso-
lated fetal microcephaly should be defined as a fetal head circumfer-
ence (as measured through ultrasound) at least three SDs below the 
mean for gestational age.9
Based on the definition that relies solely on a third percentile 
or two SD cut-off, we should expect approximately 2%-3% of new-
borns to have microcephaly.5,8 Additionally, if we are studying a 
population specifically because we suspect an excess number of 
cases (as in the setting of Zika epidemics), we would expect to ob-
serve an even greater prevalence using such a definition. However, 
several recent surveillance studies from South America that cited 
these definitions have reported a far lower prevalence of micro-
cephaly, with estimates varying between 1 and 12 in 10 000 children 
(from 0.01% to 0.12%).10-13 Of these four studies, two specify that 
additional clinical, laboratory, or radiological criteria are required 
for case confirmation though these criteria are not specified.11,12 
In the two remaining studies, there is no further explanation of the 
criteria used to diagnose microcephaly beyond the head circumfer-
ence cut-off.10,13 Surveillance studies conducted throughout the 
US during a similar time period have emphasised the need for ad-
ditional neuroimaging and clinical diagnosis, but the exact types of 
clinical evaluation were not always specified or consistent across 
these studies.14-16
This gap between the expected 2%-3% prevalence, derived 
from the cut-off-based definition, and the reported prevalence of 
0.01%-0.12% in some studies could be due to several factors. For 
example, this discrepancy could result from a larger mean head cir-
cumference in the studied populations compared to the reference 
populations, an increased level of protective factors that reduce 
the risk of microcephaly in the studied populations, or systematic 
under-reporting of microcephaly. Additionally, measuring newborn 
head circumference in the typical hospital setting may be error-
prone due to difficulty in obtaining accurate measurements and 
changes in head shape following birth.2 And using brain imaging 
(sometimes repeatedly over time) to confirm a diagnosis may not 
be feasible during large-scale Zika epidemics or in resource-limited 
settings. It is notable, as well, that the reported prevalence from 
these studies is more consistent with the SMFM definition (head 
circumference cut-off for fetal microcephaly three SDs below the 
mean, about 0.135% of a normal distribution).9
We hypothesise, however, that the prevalence estimates re-
ported in studies are valid and that the differences between the 
expected prevalence derived from the cut-off-based definition 
and the reported prevalence estimates are due to the use of addi-
tional, sometimes-unreported diagnostic criteria beyond newborn 
head circumference. As noted in some studies, classification of an 
infant with microcephaly has been reported to include diagnosis 
of brain abnormalities (intracranial calcifications, cerebral atro-
phy, etc)15 in conjunction with small head circumference; how-
ever, these diagnostic criteria are sometimes left unspecified and 
remain unclear.
The confusion in the extant literature gives rise to the possi-
bility that some investigators may use (perhaps inadvertently) a 
cut-off-based definition of microcephaly in research. While such 
sensitive definitions may be appropriate for use in large-scale sur-
veillance, they may lead us astray in research that requires more 
specific identification of microcephaly cases. For example, mis-
classification of pathological microcephaly equally among Zika-
exposed and Zika-unexposed infants (ie non-differential outcome 
misclassification) could lead to biased estimates of the causal effect 
of Zika virus on pathological microcephaly, likely towards the null 
F I G U R E  1   Example of a bimodal distribution with superimposed 
normal curves. The histogram is the bimodal distribution with 20% 
at mean −4, SD 1, and 80% at mean 0, SD 1. The two curves are 
both normal curves with mean (SD) as follows: dashed line, −4 (1); 
solid line, 0 (1)
Synopsis
Study Question
What are the implications of conducting epidemiologic re-
search using the current definition of microcephaly that relies 
on a cut-off of newborn or fetal head circumference?
What’s already known
Microcephaly is a rather rare condition with reported preva-
lence estimates varying between 1 and 12 per 10 000 children 
even though it is defined as a newborn or fetal head circum-
ference less than the third percentile in the population.
What this study adds
This study addresses the discrepancy between the definition 
of microcephaly based on newborn or fetal head circumfer-
ence and the reported estimates of microcephaly prevalence.
if the misclassification is non-differential with respect to exposure 
status. In the remainder of this report, we explore the scale of mis-
classification bias that may be introduced through using a more 
sensitive cut-off-based definition, if we assume that the more spe-
cific, clinical definitions represent true pathological microcephaly 
prevalence.
2  | METHODS
Suppose that the distribution of newborn head circumference takes 
on a bimodal distribution (Figure 1), of which a proportion of the 
population has microcephaly (left mode of the distribution, centred 
over −4) and the remainder of the population does not have micro-
cephaly and is considered healthy (right mode, centred over 0).
To illustrate how the current definition of microcephaly performs 
under such a bimodal distribution of head circumference, we con-
structed several scenarios. For the true pathological distribution, 
we set the mean at different Z‐scores (−3, −4, −5), with cut‐offs for 
defining pathological microcephaly at Z‐scores of −2, −3, and −4; the 
mean of the pathological distribution was constrained to be always 
less than the cut-off (Table 1). We then calculated the sensitivity and 
specificity for each of these six scenarios. To understand the impli-
cations of varying sensitivity and specificity, we plotted the positive 
predictive value (PPV) by different estimates of pathological micro-
cephaly prevalence in the entire population. We set the prevalence 
at 0.01%, 0.1%, 1%, and 10% and then calculated the PPV (Figure 2).
3  | RESULTS
Generally, as the distance between the pathological mean (the mean 
of the true pathological distribution) and the testing cut-off grows, 
more true-positive cases of pathological microcephaly are cap-
tured allowing the sensitivity to increase. The greatest sensitivity 
is achieved in scenario D, where the pathological mean is set to a 
Z‐score of −5 and the Z‐score cut‐off for testing for pathology is −2 
(three SDs between the mean and cut-off). The sensitivity is low-
est in scenarios A, C, and F where there is only one SD between 
the pathological mean and testing cut-off. On the other hand, the 
specificity increases as the cut-off for pathological microcephaly 
gets farther from 0 (the healthy mean, the mean of the truly healthy 
individuals) since fewer false-positive cases are captured.
The highest PPV of 99.97% was achieved at a prevalence of 
10% in scenario F, since the specificity is 99.99997% (very few 
false positives) (Figure 2F). In scenarios C and E, where the spec-
ificity is 99.9%, we see PPVs of at least 90% starting at 1% prev-
alence, but in scenarios A, B, and D, the highest PPV achieved is 
capped between 80% and 83%, and only when the prevalence 
of pathological microcephaly is highest at 10%. Notably, under 
what we believe might be a realistic scenario (eg true prevalence 
0.01%‐0.1%; pathological mean = −4; cut‐off = −2) PPV is ex-
tremely low at 0.42%-4.1% (Figure 2B).
4  | COMMENT
The number of cases of microcephaly reported in recent publications 
is lower than we would expect given formal cut-off definitions for mi-
crocephaly. This suggests the possibility of misclassification in either 
the formal cut-off definitions (which may have high sensitivity but low 
specificity) or the reported cases (which may have high specificity but 
low sensitivity). Simulations demonstrate that if the true prevalence of 
microcephaly is approximately what is being reported in peer-reviewed 
literature,10-13 then relying on the formal cut-off definitions may lead 









A −3 −2 84.1% 97.7%
B −4 −2 97.7% 97.7%
C −4 −3 84.1% 99.9%
D −5 −2 99.9% 97.7%
E −5 −3 97.7% 99.9%
F −5 −4 84.1% 100.0%a
Each row of the table estimates sensitivity and specificity assuming two normal distributions: one 
for non-pathological newborns (not shown mean 0 for all rows; SD 1), and one for true pathology 
(mean as shown by row; SD 1). Third column of table shows Z-score cut-off at which we define 
pathology. Thus, in scenario A, we report sensitivity and specificity when (a) head circumference 
among truly microcephalic newborns has a normal distribution with mean −3, SD 1; and (b) if we 
define pathology as “any head circumference below a Z‐score of −2.” Note that sensitivity changes 
with the relationship between true pathology and pathological cut-off, but (since non-pathological 
heads have the same distribution in every case) specificity changes with pathological cut-off only.
aTrue value is 99.99997%. 
TA B L E  1   Sensitivity and specificity for 
different definitions of pathological head 
circumference
While the assumptions of normality (or bimodality) in our illus-
trations may be violated in observed populations, the exact numbers 
reported in the Figures and Table are meant to illustrate probable 
misclassification using the more sensitive, but less specific cut-off-
based definition of microcephaly; similar principles would apply with 
non-normal distributions. We do not discount the importance of 
growth metrics, such as head circumference, to indicate health sta-
tus (especially in low-resource settings), due to the relative ease with 
which they are measured. We suggest, instead, further transparency 
in the reporting of methods used for defining microcephaly and high-
light the need to further research around this methodological issue.
5  | CONCLUSIONS
In conclusion, clinicians and researchers should recognise that the 
current official cut-off-based definitions of microcephaly—while 
potentially useful in surveillance contexts—are difficult to resolve 
against reported prevalence figures in the literature. If this contra-
diction is because of the use of additional diagnostic criteria in clini-
cal practice, then documentation of these additional criteria in the 
reported definition of microcephaly will be an important contribu-
tion to our understanding of microcephaly and reproducibility across 
studies. On the contrary, if the discrepancy is due to under-reporting 
F I G U R E  2   Positive predictive value and prevalence estimates with varying sensitivity (Se) and specificity (Sp). Note that the x-axis on all 





and delays in diagnosis, then surveillance efforts should be as-
sessed and improved in order to capture the full scope of disease. 
Furthermore, it is important to acknowledge that the disconnect be-
tween the definition of microcephaly and observed prevalence esti-
mates has the potential to lead to biased estimates of the association 
between Zika virus (or other possible causes) and microcephaly. We 
suggest further methodological work in this field to elucidate the 
most valid definitions of microcephaly that minimise misclassifica-
tion and subsequent biases.
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